scholarly journals Complete response to capecitabine in a frail, elderly patient with metastatic colorectal cancer: A case report

2016 ◽  
Vol 13 (2) ◽  
pp. 979-983
Author(s):  
Morena Fasano ◽  
Alessio Fabozzi ◽  
Guido Giordano ◽  
Filippo Venturini ◽  
Gaetano Aurilio ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Elderly Patient ◽  
Case Report ◽  
Metastatic Colorectal Cancer ◽  
Frail Elderly ◽  
Complete Response ◽  
Frail Elderly Patient

Gastric candidiasis in a frail elderly patient: A case report

2016 ◽  
Vol 7 (4) ◽  
pp. 364-365 ◽  
Author(s):  
S.-J. Yoon ◽  
J.-Y. Choi ◽  
S.-W. Kim ◽  
E.-S. Jang ◽  
K.-S. Lee ◽  
...  
Keyword(s):  
Elderly Patient ◽  
Case Report ◽  
Frail Elderly ◽  
Frail Elderly Patient

scholarly journals Complete Response of Pulmonary Metastases from Rectal Cancer to Tegafur-Uracil/Leucovorin plus Bevacizumab in an Elderly Patient: A Case Report

2018 ◽  
Vol 11 (2) ◽  
pp. 461-466
Author(s):  
Masatsune Shibutani ◽  
Kiyoshi Maeda ◽  
Hisashi Nagahara ◽  
Tatsunari Fukuoka ◽  
Yasuhito Iseki ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Elderly Patient ◽  
Rectal Cancer ◽  
Elderly Patients ◽  
Metastatic Colorectal Cancer ◽  
Treatment Cycle ◽  
Pulmonary Metastases ◽  
Intensive Therapy ◽  
Complete Response ◽  
Curative Surgery

As a result of recent major advances in chemotherapy for metastatic colorectal cancer, the prognosis for patients with metastatic colorectal cancer has improved. However, elderly patients often cannot receive intensive therapy. There are still many problems to solve regarding treatment for elderly patients with metastatic colorectal cancer. We herein report a case of complete response of pulmonary metastases from rectal cancer to tegafur-uracil (UFT)/leucovorin (LV) + bevacizumab (Bmab) in an elderly patient. An 80-year-old woman who had undergone curative surgery for rectal cancer 5 years ago was diagnosed with pulmonary metastases. Taking into account her advanced age and low renal function (creatinine clearance: 41.2 mL/min), UFT/LV + Bmab therapy was selected. The patient received UFT (300 mg/m2/day) and LV (75 mg/day) on days 1–5, 8–12, and 15–19 and Bmab (7.5 mg/kg) on day 1. The treatment cycle was repeated every 21 days. Following 17 courses of treatment without adverse events, a complete response was observed. Furthermore, there was no recurrence within 6 months after the final course of therapy. This case indicates that UFT/LV + Bmab is suitable for the treatment of elderly patients with metastatic colorectal cancer.

Case Report: Herpes Simplex Esophagitis in a Frail Elderly Patient

2014 ◽  
Vol 15 (12) ◽  
pp. 955-956
Author(s):  
Julio Noda ◽  
Shannon Devlin ◽  
Gerald M. Mahon ◽  
Weigang Zhu
Keyword(s):  
Elderly Patient ◽  
Case Report ◽  
Herpes Simplex ◽  
Frail Elderly ◽  
Frail Elderly Patient

Improving perioperative outcomes in the frail elderly patient

2019 ◽  
Vol 85 (11) ◽  
Author(s):  
Manuel Á. Gómez-Ríos ◽  
Rubén Casans-Francés ◽  
Alfredo Abad-Gurumeta
Keyword(s):  
Elderly Patient ◽  
Frail Elderly ◽  
Perioperative Outcomes ◽  
Frail Elderly Patient

scholarly journals The Role of Dynamic ctDNA Monitoring During Combination Therapies of BRAF V600E-Mutated Metastatic Colorectal Cancer: A Case Report

2020 ◽  
Vol Volume 13 ◽  
pp. 11849-11853
Author(s):  
Zhan Wang ◽  
Chen-Yang Ye ◽  
Wen-Li Zhou ◽  
Miao-Miao Wang ◽  
Wei-Ping Dai ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Case Report ◽  
Metastatic Colorectal Cancer ◽  
Braf V600e ◽  
Combination Therapies

Incremental hemodialysis, a valuable option for the frail elderly patient

2019 ◽  
Vol 32 (5) ◽  
pp. 741-750 ◽  
Author(s):  
Carlo Basile ◽  
Francesco Gaetano Casino ◽  
Filippo Aucella
Keyword(s):  
Elderly Patient ◽  
Frail Elderly ◽  
Frail Elderly Patient ◽  
Incremental Hemodialysis
Sign in / Sign up

Export Citation Format

Share Document